A fully human monoclonal antibody targeting PD-L1 with potent anti-tumor activity.
Luan Y, Chai D, Peng J, Ma S, Wang M, Ma H, Li X, Fu S, Pan X, Wang X, Qin S, Xu T.
Luan Y, et al. Among authors: ma s, ma h.
Int Immunopharmacol. 2016 Feb;31:248-56. doi: 10.1016/j.intimp.2015.12.039. Epub 2016 Jan 12.
Int Immunopharmacol. 2016.
PMID: 26773772